# Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC

> **NCT01229839** · PHASE3 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 668 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **OTHER:** Embolization
- **OTHER:** Infusion of anticancer agent
- **OTHER:** Infusion of mixture of anticancer agent and lipiodol

## Key facts

- **NCT ID:** NCT01229839
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 668 (ESTIMATED)
- **Last updated:** 2019-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01229839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01229839, "Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01229839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*